DreamCIS, Inc. Stock

Equities

A223250

KR7223250002

Healthcare Facilities & Services

End-of-day quote Korea S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
3,260 KRW -0.15% Intraday chart for DreamCIS, Inc. -2.69% +0.15%
Sales 2022 38.87B 28.07M Sales 2023 47.84B 34.54M Capitalization 75.04B 54.18M
Net income 2022 4.4B 3.18M Net income 2023 3.74B 2.7M EV / Sales 2022 1.13 x
Net cash position 2022 17.56B 12.68M Net cash position 2023 16.79B 12.12M EV / Sales 2023 1.22 x
P/E ratio 2022
13.8 x
P/E ratio 2023
20.8 x
Employees 236
Yield 2022 *
-
Yield 2023
-
Free-Float 28.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.15%
1 week-2.69%
1 month+8.31%
3 months+14.39%
6 months-0.31%
Current year+0.15%
More quotes
1 week
3 210.00
Extreme 3210
3 480.00
1 month
2 915.00
Extreme 2915
4 600.00
Current year
2 610.00
Extreme 2610
4 600.00
1 year
2 610.00
Extreme 2610
9 750.00
3 years
2 370.00
Extreme 2370
9 750.00
5 years
2 370.00
Extreme 2370
9 750.00
10 years
2 370.00
Extreme 2370
9 750.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 55 -
Members of the board TitleAgeSince
Chief Executive Officer 56 -
Director/Board Member 43 -
Director of Finance/CFO 55 -
More insiders
Date Price Change Volume
24-05-31 3,260 -0.15% 90,785
24-05-30 3,265 -3.26% 173,190
24-05-29 3,375 +1.50% 316,964
24-05-28 3,325 -0.60% 136,045
24-05-27 3,345 -0.15% 186,608

End-of-day quote Korea S.E., May 30, 2024

More quotes
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A223250 Stock